Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Biomechanical Ratchet Traps Cancer Cells Before They Can Spread

By LabMedica International staff writers
Posted on 29 Jun 2009
Researchers have demonstrated the possibility of using a biomechanical ratchet to sort normal and cancerous cells as a means to trap tumor cells before they spread to other areas of the body. More...


In several important physiologic processes, particularly cancer metastasis, randomly moving cells can acquire a directional motility phenotype and bias their motions in response to environmental cues. Researchers still do not understand why cells migrate in a specific direction.

In the current study, researchers from Northwestern University (Evanston, IL, USA) incorporated molecular cues (cell-adhesive and cell-repellant chemical compounds) into a "microgeometry” substrate that was keyed to the difference in shape between normal epithelial (long and thin with long protrusions on the ends) and cancer (round and broad) cells.

The microscopic ratchets contained channels with "spikes” protruding at 45o angles from the walls, alternating on opposite sides of the channel. This pattern funneled cancer cells in one direction while at the same time directing the normal cells in the opposite direction, as those cells could attach to the spikes and pull themselves through the channel. The cancer cells could be channeled into a closed chamber from which they could not escape.

The feasibility of the system was tested using melanoma, breast cancer, and normal cells, and the results were reported in the June 14, 2009, online edition of the journal Nature Physics.

"We have demonstrated a principle that offers an unconventional way to fight metastasis, a very different approach from other methods, such as chemotherapy,” said senior author Dr. Bartosz Grzybowski, associate professor of chemical and biological engineering at Northwestern University. "These are fundamental studies so the method needs to be optimized, but the idea has promise for a new approach to cancer therapy.”

Related Links:

Northwestern University



Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.